FINZALA
Live / Registered — Registered (as of 30 Jul 2024)
What this means for you
Registered since 30 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90167486
- Registration number
- 7463748
- Mark type
- Stylized text
- Filed
- 09 Sept 2020
- Published for opposition
- 23 Feb 2021
- Registered
- 30 Jul 2024
Goods and services
- Class 005 — Pharmaceuticals: Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment of neurological diseases, respiratory diseases, cancer and pain
Owner
- Teva Women's Health, LLC, Cincinnati, OH, US
- Teva Women's Health, LLC, Parsippany, NJ, US
- Teva Women's Health, LLC, Parsippany, NJ, US
Prosecution history
- 30 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 21 Jun 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Jun 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Jun 2024 — ASSIGNED TO LIE
- 06 May 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Apr 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Apr 2024 — NON-FINAL ACTION E-MAILED
- 26 Apr 2024 — SU - NON-FINAL ACTION - WRITTEN
- 22 Apr 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Apr 2024 — USE AMENDMENT FILED
- 18 Apr 2024 — TEAS STATEMENT OF USE RECEIVED
- 24 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED